Latest Visual acuity Stories
Astronauts who spend a prolonged amount of time in space could experience problems with their eyesight.
Dr. Ed Ruthazer is a mapmaker but, his landscape is the developing brain - specifically the neuronal circuitry, which is the network of connections between nerve cells.
RANCHO CORDOVA, Calif., June 14, 2011 /PRNewswire/ -- NBA star and Sacramento Kings guard Tyreke Evans knows that success in basketball doesn't rest solely on athletic ability. To put a 9.39-inch diameter ball into a hoop with an 18-inch diameter, you need healthy vision.
MOUNTAIN VIEW, Calif., May 4, 2011 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that leading clinicians have performed and published the results of a new study* that compares the benefits of MicroPulse photocoagulation technology, similar to that used in the new generation IRIDEX lasers, over the standard-of-care protocol for the treatment of eyes with diabetic macular edema (DME).
MONROVIA, Calif., April 28, 2011 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced CE Mark approval for its nanoFLEX(TM) CollamerÂ® Single Piece IOL which can be injected through a 2.2 mm incision with the nanoPOINT(TM) Injector System.
TARRYTOWN, N.Y., Feb. 22, 2011 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced that the company submitted a Biologics License Application (BLA) to the U.S.
On Monday, a federal expert panel backtracked on its 2004 recommendation to screen all kids younger than five years for poor vision, lazy eye and other eye conditions.
A Massachusetts-based company has been given Food and Drug Administration (FDA) approval to conduct a trial in which embryonic stem cells will be used to treat individuals suffering from an eye condition that can lead to blindness.
TARRYTOWN, N.Y. and BERLIN, Nov. 22, 2010 /PRNewswire-FirstCall/ -- Regeneron Pharmaceuticals, Inc.